1. Home
  2. ATYR vs VFF Comparison

ATYR vs VFF Comparison

Compare ATYR & VFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • VFF
  • Stock Information
  • Founded
  • ATYR 2005
  • VFF 1989
  • Country
  • ATYR United States
  • VFF United States
  • Employees
  • ATYR N/A
  • VFF N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • VFF
  • Sector
  • ATYR Health Care
  • VFF
  • Exchange
  • ATYR Nasdaq
  • VFF Nasdaq
  • Market Cap
  • ATYR 535.0M
  • VFF 192.1M
  • IPO Year
  • ATYR 2015
  • VFF N/A
  • Fundamental
  • Price
  • ATYR $1.08
  • VFF $2.63
  • Analyst Decision
  • ATYR Buy
  • VFF Buy
  • Analyst Count
  • ATYR 6
  • VFF 1
  • Target Price
  • ATYR $8.88
  • VFF N/A
  • AVG Volume (30 Days)
  • ATYR 14.2M
  • VFF 2.6M
  • Earning Date
  • ATYR 11-06-2025
  • VFF 11-06-2025
  • Dividend Yield
  • ATYR N/A
  • VFF N/A
  • EPS Growth
  • ATYR N/A
  • VFF N/A
  • EPS
  • ATYR N/A
  • VFF 0.09
  • Revenue
  • ATYR N/A
  • VFF $340,176,000.00
  • Revenue This Year
  • ATYR $420.85
  • VFF N/A
  • Revenue Next Year
  • ATYR $1,919.44
  • VFF $8.50
  • P/E Ratio
  • ATYR N/A
  • VFF $28.43
  • Revenue Growth
  • ATYR N/A
  • VFF 42.14
  • 52 Week Low
  • ATYR $1.00
  • VFF $0.45
  • 52 Week High
  • ATYR $7.29
  • VFF $3.39
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 22.44
  • VFF 54.15
  • Support Level
  • ATYR $1.00
  • VFF $2.38
  • Resistance Level
  • ATYR $6.50
  • VFF $2.79
  • Average True Range (ATR)
  • ATYR 0.46
  • VFF 0.26
  • MACD
  • ATYR -0.42
  • VFF -0.07
  • Stochastic Oscillator
  • ATYR 1.45
  • VFF 37.70

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About VFF Village Farms International Inc.

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Leli . The company makes majority of its revenue from the Produce segment.

Share on Social Networks: